At the March OHRC meeting in Claremore, OK, members of the Oklahoma Horse Racing Commission voted to amend the current contraband rule to read as follows:
Nor shall any person have in his/her possession within the enclosure the drug Clenbuterol other than in a form approved by the FDA, which approval currently allows the use of Clenbuterol under two brand names, Ventipulmin Syrup and Aeropulmim Syrup,. Possession within the enclosure of any form of Clembuterol other than the Venmtipulmin Syrup and Aeropulmin Syrup, in their original container, the container in which the drug was distributed by its manufacturer, is prohibited.
The revised rule was adopted as both as an emergency rule which will go into effect as soon as it is approved by Governor Fallin and under permanent rulemaking. Possession by anyone within the enclosure will result in strong penalties according the the discussion by Commissioners and staff during the meeting. Executive Director Constantine Rieger told horsemen at the meeting that the law enforcement division of the Commission will be vigilant in conducting random and unannounced searches in the barn area to seek out and eliminate the contraband Clenbuterol at all Oklahoma racetracks. The penalty for possession of contraband can be a suspension of up to one year, and a fine of up to $2,500.
Further action to discourage the illegal or inappropriate uses of Clenbuterol include a a reduction of the permitted level of Ventipulium or Aeropulium, the only FDA approved forms of Clenbuterol in post-race testing of racehorses. Effective APRIL 10, 2012 the OHRC approved level will drop from 500 pg/ml to 275 pg/ml. This level will apply on that date to ALL Breeds racing in Oklahoma.
Additionally, effective MAY 4, 2012, THE APPROVED LEVEL FOR QUARTER HORSE, PAINT, AND APPALOOSA HORSES racing in Oklahoma will be further reduced to 25 pg/ml. The lower level for Quarter Horses was approved with a delayed implentation to provide up to 45 days for horses being treated in a manner permitted under the old 500 pg/ml level adequate time to withdraw those horses from the drug and allow the drug to clear a horses system completely once the use is discontinued. This is similar to the process used by the commission in eliminating the use of anabolic steriods in 2011. The AQHA and the OQHRA both supported a lower level for the Quarter Horse, Paint, and Appaloosa's racing in Oklahoma and provided reasonable justification for the commission to approve a different level for those breed.
In other action keeping with the Commission's intention to keep Oklahoma racing free from influence of illegal and non-permitted medications, the rules regarding taking of samples were amended to provide for the track veterinarian to take samples for drug testing from catastrophically injured horses prior to administering any other drugs as may be required for the welfare of the injured horse. The amendments provide that while a trainer may witness the collection of samples in those situations, the track veterinarian may also identify witnesses from those present at the time the sample is drawn if the trainer is not immediately available.
A rule on labeling of medications was passed over as the horsemen and the commission staff agreed it needed more work, but the commissioners also approved an amendment to the Oklahoma Breeding Development Fund that will provide additional financial resources for equine research and the necropsy program.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2018 Paulick Report.